Skip to content
Accessible Unlicensed Requires Authentication Published by De Gruyter February 21, 2017

Evaluation of biotin interference on immunoassays: new data for troponin I, digoxin, NT-Pro-BNP, and progesterone

Théo Willeman, Olivier Casez, Patrice Faure and Anne Sophie Gauchez

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


1. Sedel F, Papeix C, Bellanger A, Touitou V, Lebrun-Frenay C, Galanaud D, et al. High doses of biotin in chronic progressive multiple sclerosis: a pilot study. Mult Scler Relat Disord 2015;4:159–69.Search in Google Scholar

2. Baumgartner MR, Suormala T. Biotin-responsive disorders. In: Saudubray JM, Van Den Berghe G, Walter H J, editors. Inborn Metabolic Diseases, Volume 27. Berlin, Heidelberg: Springer-Verlag, 2012:376–84.Search in Google Scholar

3. Kummer S, Hermsen D, Distelmaier F. Biotin treatment mimicking graves’ disease. N Engl J Med 2016;375:704–6.Search in Google Scholar

4. Piketty ML, Polak M, Flechtner I, Gonzales-Briceño L, Souberbielle JC. False biochemical diagnosis of hyperthyroidism in streptavidin-biotin-based immunoassays: the problem of biotin intake and related interferences. Clin Chem Lab Med 2017;55:780–8.Search in Google Scholar

5. Peyro Saint Paul L, Debruyne D, Bernard D, Mock DM, Defer GL. Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis. Expert Opin Drug Metab Toxicol 2016;12:327–44.Search in Google Scholar

6. Layfield C, Rose J, Alford A, Snyder SR, Apple FS, Chowdhury FM, et al. Effectiveness of practices for improving the diagnostic accuracy of non ST elevation myocardial infarction in the emergency department: a laboratory medicine best practices™ systematic review. Clin Biochem 2015;48:204–12.Search in Google Scholar

7. Fatemi HM, Van Vaerenbergh I. Significance of premature progesterone rise in IVF. Curr Opin Obstet Gynecol 2015;27:242–8.Search in Google Scholar

Supplemental Material:

This article (DOI: contains supplementary material, available to authorized users.

Received: 2016-10-30
Accepted: 2017-1-4
Published Online: 2017-2-21
Published in Print: 2017-8-28

©2017 Walter de Gruyter GmbH, Berlin/Boston